Resmed Inc. buy Royal Bank of Canada
Start price
01.08.25
/
50%
€241.30
Target price
01.08.26
€262.86
Performance (%)
-3.56%
Price
02.09.25
€232.70
Summary
This prediction is currently active. With a performance of -3.56%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 01.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -5.020% | -5.020% |
| iShares Core DAX® | -2.458% | 0.524% |
| iShares Nasdaq 100 | -1.226% | 1.491% |
| iShares Nikkei 225® | -1.984% | 3.351% |
| iShares S&P 500 | -0.767% | 2.346% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Royal Bank Of Canada from $294.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat